- Home
- AIMD vs BFRI Comparison
AIMD vs BFRI Comparison
Compare AIMD & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIMD | BFRI |
|---|---|---|
| Founded | 1984 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 9.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIMD | BFRI |
|---|---|---|
| Price | $2.23 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 35.6K | ★ 101.5K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $113,037.00 | ★ $37,164,000.00 |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | N/A | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 178.19 | 5.11 |
| 52 Week Low | $1.78 | $0.54 |
| 52 Week High | $5.00 | $1.87 |
Technical Indicators
Market Signals| Indicator | AIMD | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 42.05 |
| Support Level | $2.12 | $0.77 |
| Resistance Level | $2.56 | $0.83 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 62.82 | 41.70 |
Price Performance
Historical ComparisonAbout AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.